Physician profile
Sylvia Kwon
NPI 1538461405
$866.43
in general payments reported to CMS, 2019-2025
17 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $186 · 2023: $139 · 2024: $196 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $226.88 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $134.83 | 2021-2023 | |
| Glaxosmithkline, LLC. | $83.53 | 2023-2025 | Shingrix, Arexvy |
| Novo Nordisk INC | $77.24 | 2021-2022 | |
| Pfizer INC. | $76.38 | 2021-2025 | |
| Dexcom, INC. | $35.80 | 2025 | Dexcom G6 Transmitter |
| Amgen INC. | $33.00 | 2021-2023 | Otezla, Repatha |
| Boston Scientific Corporation | $32.43 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $30.26 | 2022-2023 | Fasenra |
| Xeris Pharmaceuticals, INC. | $24.64 | 2024 | Gvoke Hypopen |
| Exact Sciences Corporation | $18.80 | 2024 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.03 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.18 | 2022 | |
| Aimmune Therapeutics, INC. | $15.99 | 2024 | |
| Paratek Pharmaceuticals, INC. | $14.96 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13.79 | 2024 | Freestyle Libre 3 |
| Phadia US INC. | $12.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvia Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.